Table 4.
Predictors for SNF Success in Outcomes at 6 Months - Established Cancer Patients (OR (95% CI) unless otherwise specified)
| Variable | Any Treatment | Death | Hospice | Hospice LOS < 3 | 30-day Readmission | Months to Death HR* (95% CI) |
|---|---|---|---|---|---|---|
| N=1411 | N=1397 | N=805 | N=460 | N=1397 | N=1397 | |
| c=0.64 | c=0.75 | c=0.66 | c=0.57 | c=0.62 | ||
| Male (vs. Female) | 1.66 (1.30–2.11) | 1.22 (1.08–1.37) | ||||
| Age (years) at Index Admission | 0.96 (0.94–0.98) | 1.015 (1.01–1.024) | ||||
| Months between Diagnosis and Index Admission | 0.95 (0.93–0.97) | |||||
| White NH (vs. Other) | 1.54 (0.99–2.38) | |||||
| Married or Partnered (vs. Non-married) | ||||||
| Urban | 1.85 (1.15–2.98) | 1.27 (1.001–1.61) | ||||
| SES | ||||||
| Per Capita Income ($1000) | ||||||
| Median Income ($1000) | ||||||
| % of Residents below Poverty | ||||||
| % of Non-High School Grads | ||||||
| Charlson Comorbidity Index Categories | 1.16 (1.04–1.29) | |||||
| Cancer Type (vs. Colorectal) | ||||||
| Lung | 2.83 (2.05–3.92) | 1.32 (0.97–1.79) | 1.85 (1.53–2.22) | |||
| Pancreas | 3.55 (2.23–5.65) | 1.07 (0.68–1.69) | 2.36 (1.86–3.00) | |||
| Bladder | 1.66 (0.93–2.97) | 2.07 (1.26–3.41) | 1.2 (0.87–1.70) | |||
| Cancer Stage (vs. Stage IV) | ||||||
| Stage II | 0.60 (0.45–0.80) | 0.31 (0.22–0.42) | 0.74 (0.54–1.02) | 0.52 (0.44–0.61) | ||
| Stage III | 0.94 (0.73–1.22) | 0.33 (0.24–0.44) | 0.71 (0.53–0.94) | 0.55 (0.47–0.63) | ||
| Grade** (vs. 9) | ||||||
| 1 | 0.33 (0.17–0.64) | 0.54 (0.38–0.76) | ||||
| 2 | 0.55 (0.39–0.77) | 0.71 (0.59–0.85) | ||||
| 3 | 0.74 (0.54–1.002) | 0.87 (0.75–1.01) | ||||
| 4 | 1.28 (0.71–2.31) | 1.02 (0.75–1.40) | ||||
| Prior to Index Admission | ||||||
| One or More SNF Stays | ||||||
| Any Therapy | ||||||
| Chemotherapy | 0.67 (0.52–0.87) | |||||
| Radiation | 1.68 (1.28–2.20) | 1.18 (1.04–1.34) | ||||
| Targeted Chemotherapy | 2.34 (1.18–4.62) | |||||
| HTN | 0.74 (0.55–0.99) | 0.82 (0.72–0.94) | ||||
| Diabetes | ||||||
| COPD | 1.16 (1.02–1.32) | |||||
| Heart | ||||||
| Stroke | 0.47 (0.25–0.89) | |||||
| Cognitive | 0.44 (0.27–0.69) | 1.84 (1.17–2.88) | ||||
| Alcohol | 2.39 (1.23–4.63) | |||||
| Depression | 1.60 (1.08–2.38) | |||||
| Index Hospital | ||||||
| Region (vs. West) | ||||||
| Northeast | 1.98 (1.40–2.81) | |||||
| Midwest | 3.90 (2.21–6.88) | |||||
| South | 1.86 (1.20–2.88) | |||||
| Location: Urban (vs. Rural) | 2.01 (1.22–3.33) | 0.69 (0.53–0.91) | ||||
| Type: Teaching (vs. Non-teaching) | 0.76 (0.60–0.96) | 0.85 (0.76–0.96) | ||||
| LOS | 0.96 (0.94–0.99) | 0.92 (0.86–0.99) | 1.03 (1.01–1.05) | |||
| Discharge Year |
*
Hazard Ratio
**
Grade I: well differentiated; differentiated, NOS
Grade 2: moderately differentiated; moderately differentiated; intermediate differentiation
Grade 3: poorly differentiated; differentiated
Grade 4: undifferentiated; anaplastic
Grade 9: cell type not determined, not stated or not applicable